Effects of the hydroxamic acid derivate ro 31-4724 on the metabolism and morphology of lnterleukin-1-treated cartilage explants

Pharmacology

Volumn 55, Issue 2, 1997, Pages 95-108

  Steinmeyer, Jürgen ^a   Daufeldt, Sabine ^a   Kalbhen, Dieter A ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Cartilage; Matrix metalloproteinases; Ro 31 4724 Interleukin 1

Indexed keywords

HYDROXAMIC ACID DERIVATIVE; INTERLEUKIN 1; MATRIX METALLOPROTEINASE; PROTEOGLYCAN; RO 31 4724; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CATTLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; METABOLISM; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RHEUMATIC DISEASE;

ANIMALS; CARTILAGE, ARTICULAR; CATTLE; CULTURE TECHNIQUES; HYDROXAMIC ACIDS; INTERLEUKIN-1; METALLOENDOPEPTIDASES; PROTEASE INHIBITORS; PROTEOGLYCANS;

EID: 0030879670     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139517     Document Type: Article

References (40)

1. Chubinskaya S. Huch K. Mikecz K. Cs-Szabo G. Hasty K.A. Kuettner KI. Cole AA: Chondrocyte matrix metalloproteinase-8: Upregulation of neutrophil collagénase by interleukin-1 beta in human cartilage from knee and ankle joints. Lab Invest 1996;74:232-235.
2. Cole AA. Kuettner KE: MMP-8 mRNA and aggrecanasc cleavage products are present in normal and ostcoarthritic human articular cartilage. Acta Orthop Scand 1995:266: 98-102.
3. Fosang AJ. Ncame PJ. Last K. Har-dingham TE. Murphy G. Hamilton JA: Interglobular domain of cartilage aggrecan is cleaved by PUMP, gclatinases, and cathepsin B. J Biol Chem 1992;267:19470-19474.
4. Fosang AJ, Last K. Knäuper V. Neame PJ. Murphy G. Hardingham TE, Tschesche H. Hamilton JA: Fibroblast and neutrophil collagénases cleave at two sites in the cartilage aggrecan interglobular domain. Bio-chemJ 1993;295:273-276.
5. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990:6: 121-125.
6. Woessner JF Jr.: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASF.B J 1991;5:2145-2154.
7. Dingle JT. Page-Thomas DP. King B. Bard DR: In vivo studies of articular tissue damage mediated by ca-tabolin/interleukin I. Ann Rheum Dis 1987;46:527-533.
8. Pettipher ER. Higgs GA. Henderson B: Interleukin 1 induces leucocyte infiltration and cartilage proteoglycan degradation in the synovial joint. ProcNatl Acad Sci USA 1986; 85:8749-8753.
9. Bunning RAD, Crawford A. Richardson HJ. Opdcnakkcr G. Van Damme J, Russel RGG: Interleukin I preferentially stimulates the production of tissue-type plasminogen activator by human articular chondrocytes. Biochim Biophys Acta 1987;924:473-482.
10. Hasty KA. Rcife RA. Kang AH. Stuart JM: The role of stronieiysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum 1990:33:388-397.
11. Campbell IK. Last K. Novak U: Recombinant human interleukin 1 inhibits plasminogen activator inhibitor-1 (PA1-I) production by human articular cartilage and chondrocytes. Biochcm Biophys Res Commun 1991:174:251-254.
12. Pelletier JP, Howell DS: Etiopatho-gcncsis of osteoarthritis: in McCarthy C. Koopman WJ (cds): Arthritis and Allied Conditions. Philadelphia. Lea & Febigcr. 1993. pp 1723-1734.
13. Morales TI. Hascall VC: Factors involved in the regulation of proteoglycan metabolism in articular cartilage. Arthritis Rheum 1989:32: 1197-1201.
14. Seed MP. lsmaiel S. Cheung CY. Thomson TA, Gardner CR, Atkins RM. Elson CJ: Inhibition of interleukin 1 beta induced rat and human cartilage degradation in vitro by the metalloproteinase inhibitor U27391. Ann Rheum Dis 1993:52: 37-43.
15. Brânnstrom M. Woessner JF Jr. Koos RD. Scar CHJ. Lemaire WJ: Inhibitors of mammalian tissue collagénase and metalloproteinase suppress ovulation in the perfused rat ovary. Endocrinology 1988:122: 1715-1721.
16. Galardy RE, Grobelny D, Kortyle-wiez ZP, Poncz L: Inhibition of human skin fibroblast coliagenase by phosphorus-containing peptides; in Birkedal-Hansen Z, Werb Z. Welgus HG. Van Wart HE (eds): Matrix Metalloproteinases and Inhibitors. Stuttgart. Gustav Fischer. 1992. spec suppl 1, pp 259-262.
17. Gray RD. Miller RB. Spatola AF: Inhibition of mammalian collagénases by thiol-containing peptides. J Cell Biochcm 1986;32:71-77.
18. Johnson WH. Roberts NA. Barka-koti N: Coliagenase inhibitors: Their design and potential therapeutic use. J Enzyme lnhib 1987:2:1-22.
19. Netzel-Amett S. Mallya SK, Nagase H, Birkcdal-Hanscn Z. Van Wart HE: Continuously recording fluorescent assays optimized for five human matrix metalloproteinases. Anal Biochem 1991:195:86-92.
20. Schwartz MA, Venkataraman S. GhalTari MA. Libby A. Mookhtiar KA. Mallya SK. Birkcdal-Hanscn H, Van Wart HE: Inhibition of human collagénases by sulfur-based substrate analogs. Biochem Biophys Res Commun 1991:176:173-179.
21. Azzo W. Woessner JF: Purification and characterization of an acid metalloproteinase from human articular cartilage. J Biol Client 1986:261: 5434-5441.
22. Nagase H. Woessner JF: An improved assay for proteases and poly-saccharidascs employing a cartilage proteoglycan substrate entrapped in polyacrylamide particles. Anal Biochem 1980:107:385-392.
23. Burton-Wurster N. Lust G: Fibro-ncctin and proteoglycan synthesis in long term cultures of cartilage expiants in Ham's F-12 supplemented with insulin and calcium: Effects of the addition of TGF-p. Arch Biochem Biophys 1990;283:27-33.
24. Carney SL: Proteoglycans: in Chaplin MF. Kennedy JF (eds): Carbohydrate Analysis: A Praclial Approach. Oxford, IRL Press, 1986. pp 97-142.
25. Farndale RW. Buttle DJ. Barrett AJ: Improved quantitation and discrimination of sulphated glycosamino-glycans by use of diemthylmethy-lene blue. Biochim Biophys Acta 1986;883:173-177.
26. Famum CE. Turgai J. Wilsman N: Visualization of living terminal hypertrophic chondrocytes of growth plate cartilage in situ by differential interference contrast microscopy and time-lapse chinematography. J Orthop Res 1990:8:750-763.
27. Ohlendorf C. Tomford WW. Man-kin HJ: Chondrocyte survival in cryoprcscrved ostcochondroal articular cartilage. J Orthop Res 1996: 14:413-416.
28. Muldrcw K. Novak K. Hurtig MB. Sehachar NS, McGann LE: Cryo-preservation of articular cartilage using in vitro and in vivo assays. Trans 39st Ann Meet Orthop Res Soc 1993:18:275.
29. Mankin HJ. Dorfman H. Lippicllo L, Zarins A: Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. J Bone Joint Surg 1971 53A: 523-537.
30. Caputo CB. Wolanin DJ. Roberts RA. Sygowski LA. Patton SP, Cac-cese RG. Shaw A. Dipasquale G: Proteoglycan degradation by achon-drocytc métalloprotéase: Effects of synthetic protease inhibitors. Biochem Pharmacol 1987:36:995-1002.
31. Dipasquale G. Cacccse R. Pasternak R. Conaty J. Hubbs S, Perry K: Proteoglycan-and collagen-degrading enzymes from human interleukin-1 stimulated chondrocytes from several species: Proteoglycanase and collagenase inhibitors as potentially new discasc-modifiying antiarthritic agents. Proc Soc Exp Biol Med 1986:183:262-267.
32. Nixon JS. Bottomlev KMK. Brad-hurst MJ. Brown PA. Johnson WH, Lawton G. Marley J, Sedgwick AD. Wilkinson SE: Potent collagenase inhibitors prevent interleukin 1-induced cartilage degradation in vitro. Int J Tissue React 1991:13:237-243.
33. Schwartz MA. Van Wart HE: Synthetic inhibitors of bacterial and mammalian interstitial collagénases: in Ellis GP. Luscombe DK (cds): Progress in Medicinal Chemistry. Amsterdam. Elsevier. 1992. pp 271-334.
34. Williams RJ, Smith RL, Schurman DJ: Purified staphylococcal culture medium stimulates neutral métalloprotéase secretion from human articula r cartilage. J Orthop Res 1991:9: 258-265.
35. Witt M. Fosang AJ. Hughes CE, Hardingham TE: Changes in the pattern ofaggrccan cleavage in cartilage expiants following stimulation with IL-I alpha or retinoate and inhibition of cleavage by a metalloproteinase inhibitor. Trans 41st Ann Meet Orthop Res Soc 1995:20:122.
36. Andrews HJ. Plumpton TA. Harper GP. Cawston TE: A synthetic peptide metalloproteinase inhibitor, but not TIMP. prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions 1992; 37:147-154.
37. Ellis AJ. Curry VA. Pow-ell EK. Cowston TE: The prevention of collagen breakdown in bovine nasal cartilage by TIM P-2 and a low molecular weight synthetic inhibitor. Biochem Biophys Res Commun 1994;201:94-101.
38. Mort JS. Dodge GR. Roughley PJ. Liu J, Finch SJ. DiPasquale G, Poole AR: Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix 1993;13:95-102.
39. Buttle DJ. Handley CJ. Ilic MZ, Saklatvala J. Murata M. Barrett AJ: Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases: Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation. Arthritis Rheum 1993: 36:1709-1717.
40. Dimartino MJ, High W. Galloway WA, Crimmin MJ: Prcclinical an-liarthritic activity of matrix metalloproteinase inhibitors. Ann NY Acad Sci 1994;732:411-413.